Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Curr Top Behav Neurosci ; 59: 77-90, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-34647283

RESUMEN

Histamine H1 receptor (H1R) has a special up-regulation mechanism by the stimulation of H1R, mediated by protein kinase C-delta (PKCδ) signaling and H1R gene expression, resulting increase in H1R signaling. Increase in H1R mRNA in nasal mucosa was induced after the provocation of nasal hypersensitivity model rats and suppressed by the pre-treatment of antihistamines. Improvement of nasal symptoms and suppression of H1R mRNA expression in nasal mucosa were also observed by the pre-treatment of antihistamines in pollinosis patients. Elucidation of a correlation between symptoms and H1R mRNA level suggests that H1R gene is an allergic disease (AD)-susceptibility gene, targeted by antihistamines. Similar to antihistamines, pre-treatment of Kujin extract, an anti-allergic Kampo medicine improved nasal symptoms and suppressed H1R mRNA expression in nasal hypersensitivity model rats. (-)-Maackiain targeting heat shock protein 90 (Hsp90) was isolated as an inhibitor of PKCδ signaling-mediated H1R gene expression from Kujin extract. In addition to H1R-mediated activation of H1R gene expression as the first mechanism, nuclear factor of activated T-cells (NFAT)-mediated IL-9 gene expression is suggested to participate to allergic symptoms as the second mechanism insensitive to antihistamines. Pyrogallol and proanthocyanidin suppressing IL-9 gene expression were discovered from Awa-tea and lotus root knots, respectively. Combination therapy using medicines suppressing both H1R gene expression and IL-9 gene expression is promising for outstanding alleviation of AD. Multifactorial diseases involving H1R gene expression may be treated by the combination therapy with antihistamine and complementary drugs, and diseases involving PKCδ signaling may be treated by drugs targeting Hsp90.


Asunto(s)
Antialérgicos , Productos Biológicos , Hipersensibilidad , Proantocianidinas , Animales , Antialérgicos/farmacología , Antialérgicos/uso terapéutico , Productos Biológicos/uso terapéutico , Proteínas de Choque Térmico/uso terapéutico , Histamina/metabolismo , Histamina/uso terapéutico , Antagonistas de los Receptores Histamínicos/farmacología , Antagonistas de los Receptores Histamínicos/uso terapéutico , Humanos , Hipersensibilidad/tratamiento farmacológico , Hipersensibilidad/genética , Interleucina-9/uso terapéutico , Proantocianidinas/uso terapéutico , Proteína Quinasa C-delta/metabolismo , Proteína Quinasa C-delta/uso terapéutico , Pirogalol/uso terapéutico , ARN Mensajero/genética , ARN Mensajero/metabolismo , ARN Mensajero/uso terapéutico , Receptores Histamínicos H1/genética , Receptores Histamínicos H1/metabolismo , Receptores Histamínicos H1/uso terapéutico ,
2.
J Med Invest ; 67(3.4): 289-297, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33148904

RESUMEN

As the expression level of allergic disease sensitive genes are correlated with the severity of allergic symptoms, suppression of these gene expressions could be promising therapeutics. We demonstrated that protein kinase Cδ / heat shock protein 90-mediated H1R gene expression signaling and nuclear factor of activated T-cells (NFAT)-mediated IL-9 gene expression signaling are responsible for the pathogenesis of pollinosis. Treatment with Awa-tea combined with wild grape hot water extract suppressed these signaling and alleviated nasal symptoms in toluene-2,4-diisocyanate (TDI)-sensitized rats. However, the underlying mechanism of its anti-allergic activity is not elucidated yet. Here, we sought to identify an anti-allergic compound from Awa-tea and pyrogallol was identified as an active compound. Pyrogallol strongly suppressed ionomycin-induced up-regulation of IL-9 gene expression in RBL-2H3 cells. Treatment with pyrogallol in combination with epinastine alleviated nasal symptoms and suppressed up-regulation of IL-9 gene expression in TDI-sensitized rats. Pyrogallol itself did not inhibit calcineurin phosphatase activity. However, pyrogallol suppressed ionomycin-induced dephosphorylation and nuclear translocation of NFAT. These data suggest pyrogallol is an anti-allergic compound in Awa-tea and it suppressed NFAT-mediated IL-9 gene expression through the inhibition of dephosphorylation of NFAT. This might be the underlying mechanism of the therapeutic effects of combined therapy of pyrogallol with antihistamine. J. Med. Invest. 67 : 289-297, August, 2020.


Asunto(s)
Antialérgicos/farmacología , Interleucina-9/genética , Pirogalol/farmacología , Rinitis Alérgica Estacional/tratamiento farmacológico , Té/química , Animales , Antialérgicos/aislamiento & purificación , Células Cultivadas , Fermentación , Regulación de la Expresión Génica/efectos de los fármacos , Masculino , Factores de Transcripción NFATC/fisiología , Pirogalol/aislamiento & purificación , Pirogalol/uso terapéutico , Ratas , Ratas Endogámicas BN , 2,4-Diisocianato de Tolueno/farmacología
3.
Mar Drugs ; 16(11)2018 Nov 09.
Artículo en Inglés | MEDLINE | ID: mdl-30423960

RESUMEN

Ecklonia cava (E. cava) can alleviate vascular dysfunction in diseases associated with poor circulation. E. cava contains various polyphenols with different functions, but few studies have compared the effects of these polyphenols. Here, we comparatively investigated four major compounds present in an ethanoic extract of E. cava. These four major compounds were isolated and their effects were examined on monocyte-associated vascular inflammation and dysfunctions. Pyrogallol-phloroglucinol-6,6-bieckol (PPB) significantly inhibited monocyte migration in vitro by reducing levels of inflammatory macrophage differentiation and of its related molecular factors. In addition, PPB protected against monocyte-associated endothelial cell death by increasing the phosphorylations of PI3K-AKT and AMPK, decreasing caspase levels, and reducing monocyte-associated vascular smooth muscle cell proliferation and migration by decreasing the phosphorylations of ERK and AKT. The results of this study show that four compounds were effective for reduction of monocyte-associated vascular inflammation and dysfunctions, but PPB might be more useful for the treatment of vascular dysfunction in diseases associated with poor circulation.


Asunto(s)
Antiinflamatorios/farmacología , Dioxinas/farmacología , Monocitos/efectos de los fármacos , Phaeophyceae/química , Floroglucinol/farmacología , Extractos Vegetales/farmacología , Pirogalol/farmacología , Animales , Antiinflamatorios/química , Antiinflamatorios/aislamiento & purificación , Antiinflamatorios/uso terapéutico , Diferenciación Celular/efectos de los fármacos , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Dioxinas/química , Dioxinas/aislamiento & purificación , Dioxinas/uso terapéutico , Evaluación Preclínica de Medicamentos , Células Endoteliales/efectos de los fármacos , Células Endoteliales/fisiología , Macrófagos/efectos de los fármacos , Macrófagos/fisiología , Ratones , Monocitos/metabolismo , Monocitos/fisiología , Miocitos del Músculo Liso/efectos de los fármacos , Miocitos del Músculo Liso/fisiología , Floroglucinol/química , Floroglucinol/aislamiento & purificación , Floroglucinol/uso terapéutico , Extractos Vegetales/química , Pirogalol/química , Pirogalol/aislamiento & purificación , Pirogalol/uso terapéutico , Enfermedades Vasculares/tratamiento farmacológico
4.
J Nutr Biochem ; 41: 12-19, 2017 03.
Artículo en Inglés | MEDLINE | ID: mdl-27951515

RESUMEN

The objective of this study was to assess the underlying mechanisms of mango polyphenol decreased cell proliferation and tumor volume in ductal carcinoma in situ breast cancer. We hypothesized that mango polyphenols suppress signaling along the AKT/mTOR axis while up-regulating AMPK. To test this hypothesis, mango polyphenols (0.8 mg gallic acid equivalents per day) and pyrogallol (0.2 mg/day) were administered for 4 weeks to mice xenografted with MCF10DCIS.com cells subcutaneously (n=10 per group). Tumor volumes were significantly decreased, both mango and pyrogallol groups displayed greater than 50% decreased volume compared to control. There was a significant reduction of phosphorylated protein levels of IR, IRS1, IGF-1R, and mTOR by mango; while pyrogallol significantly reduced the phosphorylation levels of IR, IRS1, IGF-1R, p70S6K, and ERK. The protein levels of Sestrin2, which is involved in AMPK-signaling, were significantly elevated in both groups. Also, mango significantly elevated AMPK phosphorylation and pyrogallol significantly elevated LKB1 protein levels. In an in vitro model, mango and pyrogallol increased reactive oxygen species (ROS) generation and arrested cells in S phase. In silico modeling indicates that pyrogallol has the potential to bind directly to the allosteric binding site of AMPK, inducing activation. When AMPK expression was down-regulated using siRNA in vitro, pyrogallol reversed the reduced expression of AMPK. This indicates that pyrogallol not only activates AMPK, but also increases constitutive protein expression. These results suggest that mango polyphenols and their major microbial metabolite, pyrogallol, inhibit proliferation of breast cancer cells through ROS-dependent up-regulation of AMPK and down-regulation of the AKT/mTOR pathway.


Asunto(s)
Antineoplásicos Fitogénicos/uso terapéutico , Neoplasias de la Mama/dietoterapia , Carcinoma Intraductal no Infiltrante/dietoterapia , Suplementos Dietéticos , Regulación Neoplásica de la Expresión Génica , Extractos Vegetales/uso terapéutico , Polifenoles/uso terapéutico , Proteínas Quinasas Activadas por AMP/antagonistas & inhibidores , Proteínas Quinasas Activadas por AMP/química , Proteínas Quinasas Activadas por AMP/genética , Proteínas Quinasas Activadas por AMP/metabolismo , Animales , Antineoplásicos Fitogénicos/análisis , Antineoplásicos Fitogénicos/química , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/patología , Carcinoma Intraductal no Infiltrante/metabolismo , Carcinoma Intraductal no Infiltrante/patología , Línea Celular Tumoral , Proliferación Celular , Suplementos Dietéticos/análisis , Femenino , Humanos , Mangifera , Ratones Desnudos , Fosforilación , Extractos Vegetales/efectos adversos , Extractos Vegetales/química , Polifenoles/efectos adversos , Polifenoles/análisis , Procesamiento Proteico-Postraduccional , Pirogalol/efectos adversos , Pirogalol/análisis , Pirogalol/uso terapéutico , Interferencia de ARN , Especies Reactivas de Oxígeno/agonistas , Especies Reactivas de Oxígeno/metabolismo , Serina-Treonina Quinasas TOR/antagonistas & inhibidores , Serina-Treonina Quinasas TOR/genética , Serina-Treonina Quinasas TOR/metabolismo , Carga Tumoral , Ensayos Antitumor por Modelo de Xenoinjerto
5.
J Agric Food Chem ; 51(6): 1560-5, 2003 Mar 12.
Artículo en Inglés | MEDLINE | ID: mdl-12617584

RESUMEN

To evaluate the hepatoprotective activity of spices, 21 different spices were fed to rats with liver damage caused by lipopolysaccharide (LPS) plus d-galactosamine (D-GalN). As assessed by plasma aminotranferase activities, nutmeg showed the most potent hepatoprotective activity. Bioassay-guided isolation of the active compound from nutmeg was carried out in mice by a single oral administration of the respective fractions. Myristicin, one of the major essential oils of nutmeg, was found to possess extraordinarily potent hepatoprotective activity. Myristicin markedly suppressed LPS/D-GalN-induced enhancement of serum TNF-alpha concentrations and hepatic DNA fragmentation in mice. These findings suggest that the hepatoprotective activity of myristicin might be, at least in part, due to the inhibition of TNF-alpha release from macrophages. However, further studies are needed to elucidate the hepatoprotective mechanism(s) of myristicin.


Asunto(s)
Compuestos de Bencilo/uso terapéutico , Dioxolanos/uso terapéutico , Galactosamina , Lipopolisacáridos , Hepatopatías/prevención & control , Myristica/química , Pirogalol/análogos & derivados , Pirogalol/uso terapéutico , Alanina Transaminasa/sangre , Derivados de Alilbenceno , Animales , Aspartato Aminotransferasas/sangre , Compuestos de Bencilo/administración & dosificación , Compuestos de Bencilo/aislamiento & purificación , Enfermedad Hepática Inducida por Sustancias y Drogas , Fragmentación del ADN/efectos de los fármacos , Dieta , Dioxolanos/administración & dosificación , Dioxolanos/aislamiento & purificación , Hígado/química , Masculino , Ratones , Aceites Volátiles/química , Pirogalol/administración & dosificación , Pirogalol/aislamiento & purificación , Ratas , Ratas Wistar , Factor de Necrosis Tumoral alfa/análisis
6.
Contact Dermatitis ; 26(4): 241-7, 1992 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-1395561

RESUMEN

The influence of the widely used topical dermatological treatment modalities anthralin, coal tar and pyrogallol on surface markers of epidermal Langerhans cells and contact sensitization was studied and compared with that of a PUVA treatment. A common effect of all dermatological therapies tested was inhibition of Langerhans cell ATPase, whereas an effect on MHC class II antigens was found only after PUVA or tar treatment. The induction of contact hypersensitivity was inhibited only by PUVA, and not by the other treatments. These results show that various forms of topical therapy influence surface markers and immunological function of epidermal Langerhans cells differently.


Asunto(s)
Adenosina Trifosfatasas/efectos de los fármacos , Dermatitis por Contacto/tratamiento farmacológico , Antígenos de Histocompatibilidad Clase II/efectos de los fármacos , Células de Langerhans/efectos de los fármacos , Terapia PUVA , Adenosina Trifosfatasas/metabolismo , Administración Tópica , Animales , Antralina/administración & dosificación , Antralina/uso terapéutico , Alquitrán/administración & dosificación , Alquitrán/uso terapéutico , Dermatitis por Contacto/metabolismo , Antígenos de Histocompatibilidad Clase II/metabolismo , Células de Langerhans/metabolismo , Ratones , Ratones Endogámicos BALB C , Pirogalol/administración & dosificación , Pirogalol/uso terapéutico , Factores de Tiempo
7.
J Neurobiol ; 6(6): 587-96, 1975 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-1185192

RESUMEN

The activities of catechol-O-methyl transferase (COMT), monoamine oxidase (MAO), and a methanol forming enzyme were studied in whole brain homogenates and in livers obtained from DBA/2J, C57B1/6J, and F1 hybrid mice. DBA/2J mice are extremely susceptible to audiogenic seizures, whereas C57B1/6J mice are resistant to sound-induced convulsions. C57B1/6J mice were found to have significantly higher brain levels of COMT, while MAO activities were not different in animals of these genotypes. No methanol forming activity was detected in animals of either strain. No differences were found in hepatic activities of either COMT or MAO. Pyrogallol was shown to protect DBA/2J animals against audiogenic seizures.


Asunto(s)
Estimulación Acústica , Encéfalo/enzimología , Catecol O-Metiltransferasa/metabolismo , Monoaminooxidasa/metabolismo , Convulsiones/enzimología , Animales , Catálisis , Genotipo , Hibridación Genética , Cinética , Hígado/enzimología , Magnesio , Ratones , Ratones Endogámicos , Pirogalol/uso terapéutico , Convulsiones/prevención & control
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA